
Ontario Tightens Safer Supply with Supervised Dosing Requirements
Ontario is tightening safer supply prescribing: patients must take medications under professional supervision and receive opioid agonist therapy, raising concerns about access and the 12 percent who do not respond to that treatment. Dr. Chi-Ming Chow also examines a seven-day mouse-cell study of tadalafil and muscle repair, warnings about AI’s effects on healthcare workers, and Quebec’s early flu season, where free vaccines are limited to specific groups.
Key Points
- Ontario is tightening safer supply prescribing by requiring supervised dosing and pairing these medications with opioid agonist therapy to reduce diversion while preserving access for patients at high overdose risk.
- Early lab research suggests tadalafil may support muscle precursor cell survival and regeneration, but it has not been shown to build muscle in people and should not be used for that purpose without further evidence.
- AI in healthcare may improve efficiency, but it also raises serious concerns about worker surveillance, deskilling, wages, accountability, and patient care, while Quebec is urging residents to get flu shots early as respiratory virus season begins.
Chapters
| 0:00 | |
| 2:56 | |
| 10:04 |
Transcript
Loading transcript...
- / -

